Pharmacy Business

Desmopressin acetate for injection is multi-indicated for patients with central diabetes insipidus, hemophilia A and von Willebrand’s disease.

Skills in financials, operations, marketing and leadership are the focus of the program.

As of April 2024, the FDA has approved a total of 48 biosimilars across 15 unique biological molecules, and of the 48 approvals, 38 biosimilars have launched in the U.S. market, per the report.

Lupin is one of the first ANDA applicants for generic Ingrezza and is eligible for 180 days of shared generic exclusivity.

Pharmacy professionals at a CVS in Las Vegas are set to have a union election April 24.

Norwich’s ANDA for Xifaxan 550 mg remains barred from approval by the Food and Drug Administration until Oct. 2, 2029.

The organization sat down with Colleen Lindholz, president of Kroger Health, to discuss the company's involvement in NACDS RxIMPACT grassroots programs.

Alex Hurd, VP, healthcare services at Walmart Canada, discusses the differences between retail pharmacy in Canada and the United States.